Scroll for more

blog

Feb 23, 2017 bear

Bear necessities - a day in the life of an AI office dog

An increasingly large number of humans are walking through the doors at Benevolent AI HQ, fresh faced and ready to join the team

Feb 20, 2017 jackie hunter

Wither pharmaceutical innovation?

Let’s talk pharmaceutical innovation, and in doing so let’s be honest and perhaps a little controversial. Last year the CEO of Regeneron, Leonard Schleifer, stood up at the Forbes Healthcare Summit in New York and said something surprisingly candid and revealing.

Feb 8, 2017 benevolentai

What's in a name? Our first clinical trial

Recently we welcomed the news that we have officially selected a study name for BenevolentAI's first clinical trial.

Jan 11, 2017 kenneth mulvany

Is AI morality asleep at the wheel?

In an age where you could soon be legally (and safely) asleep at the wheel thanks to driverless cars will morality in AI go the same way – is the principle of ethics in AI asleep at the wheel?

Dec 21, 2016 jackie hunter

I'm buying science presents for Christmas this year

It’s the last week before Christmas and a good time for reflection, to pause for breath and to think about what the next year will bring.

Dec 5, 2016 jackie hunter

In five years' time… Key trends in AI healthcare

10 years ago I attended a symposium looking at the future of pharmacology and healthcare.

Dec 1, 2016 kenneth mulvany

Why… …we are called ‘Benevolent’?

We are developing and applying AI technology to enhance and accelerate scientific discovery by turning the world’s mass of highly fragmented scientific information into new insight and useable knowledge that ultimately benefits society.   

Oct 7, 2016 jackie hunter

What happens when you put expert human brains in a room to discuss machine brains?

These are truly exciting times for artificial intelligence (“AI”) and bioscience. This month, together with The Crick and Turing Institutes and the Wellcome Trust, we co-hosted the first of what we anticipate will be an annual symposium on ‘Artificial Intelligence in Bioscience’.